Accordingly, there is evidence that increased circulating and adipose tissue levels of VEGF-A in obesity significantly decrease in patients with a dramatic weight loss [5–7]. The gene discussed is VEGFA; the disease is obesity due to melanocortin 4 receptor deficiency.